Onco-hematologia
Diretriz | Linfomas cutâneos.
27 Abr, 2022 | 15:32hRevisão | Novos tratamentos para linfomas não Hodgkin de células B.
25 Abr, 2022 | 12:36hNovel treatments in B cell non-Hodgkin’s lymphomas – The BMJ
Comentário no Twitter
READ: new State of the Art review on novel treatments in B cell non-Hodgkin’s lymphomas.
Learn about mechanisms of action, efficacy and safety, current therapeutic roles, and future directions in treatment https://t.co/EIri6jDBcv
— The BMJ (@bmj_latest) April 22, 2022
Diretriz britânica para tratamento da leucemia linfocítica crônica.
25 Abr, 2022 | 12:22hGuideline for the treatment of chronic lymphocytic leukaemia – British Journal of Haematology
Estudo randomizado | Ivosidenibe e azacitidina na leucemia mieloide aguda IDH1-mutante.
25 Abr, 2022 | 12:20hIvosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Ivosidenib and azacitidine showed clinical benefit as compared with placebo and azacitidine in patients with newly diagnosed IDH1-mutated AML, a difficult-to-treat population. https://t.co/6K6mWJdd2V pic.twitter.com/qOwOvHcV4j
— NEJM (@NEJM) April 20, 2022
Índice de estresse e ativação endotelial (EASIX – endothelial activation and stress index) pré-transplante pode predizer danos causados por sepse após transplante alogênico de células-tronco.
21 Abr, 2022 | 11:30hPre-transplant EASIX and sepsis after allogeneic stem cell transplantation – Intensive Care Medicine
Comentário no Twitter
🧪 Endothelial complications major causes of mortality post alloSCT. Pre Tx Endothelial Activation & Stress IndeX EASIX (basic lab data characterizing Tx-associated thrombotic microangiopathy) powerful marker of #sepsis, dysfunctional endothelial response.https://t.co/FRGUGT8L78 pic.twitter.com/VF2wTLCHaM
— Intensive Care Medicine (@yourICM) April 18, 2022
Estudo de coorte | Tipo sanguíneo não O está associado a risco aumentado de tromboembolismo venoso em pacientes com câncer.
18 Abr, 2022 | 15:19hABO blood group type and risk of venous thromboembolism in patients with cancer – Blood Advances (link para o resumo – $ para o texto completo)
Revisão | Manifestações cutâneas da gamopatia monoclonal.
18 Abr, 2022 | 15:13hCutaneous manifestations of monoclonal gammopathy – Blood Cancer Journal
Revisão | Terapia de indução anterior à transplante autólogo de células-tronco no mieloma múltiplo recém-diagnosticado.
18 Abr, 2022 | 15:03hDiretrizes NCCN | Toxicidades relacionadas a terapia com CAR T Cells em pacientes com câncer.
12 Abr, 2022 | 12:31hConteúdos relacionados:
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Critical Care Management of Chimeric Antigen Receptor T Cell–related Toxicity. Be Aware and Prepared
Reviews: CAR T-Cell Therapy Toxicities and Side Effects
Estudo antes-e-depois | Gestão de antibióticos em pacientes com neutropenia febril de alto risco reduziu o uso de carbapenêmicos e glicopeptídios e foi associada com melhores desfechos clínicos.
5 Abr, 2022 | 11:52hConteúdos relacionados:
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines – Annals of Oncology
Comentário do autor no Twitter (fio – clique para saber mais)
📢 Our new study "Antimicrobial stewardship in high-risk febrile neutropenia patients." is now out in #ARIC !💥
Find our open access paper here: https://t.co/2fFoHfpEzi
And some data bellow ⬇️ (1/10) pic.twitter.com/kg4pYQs9HD
— Adrien Contejean (@AdrienContejean) March 29, 2022